April 22, 2024

Bio-Europe 2025

Bio-Europe 2025

Europe’s premier partnering event

November 3–5, 2025 | Vienna, Austria

November 11–12, 2025 | Digital Partnering

BIO-Europe will host over 29,000 one-to-one meetings. The powerful partneringONE platform allows you to effortlessly and efficiently search for your most ideal partners. BIO-Europe will feature a distinguished lineup of speakers, including leading experts and visionaries from the biotech and pharma industries, who will take you on a journey of the past 30 years of experiences, partnerships and innovation and envision trends in the next 30 years to come.


BioRN Members get a 15 %  discount.

Registration Rates

EARLY BIRD:
by July 25
by Sept. 12 by Oct. 17 by Nov. 1 on-site DIGITAL PASS w/o on-site access
R&D Company, Investor, Government €       2.695,00  €        2.895,00  €   3.195,00  €   3.495,00  €   3.795,00  €        1.695,00
Biotech & Academics Pre-Revenue Offer TWO registrations for the price of ONE. Deadline to apply: Oct. 27
Service Provider  €       3.395,00  €        3.595,00  €   4.295,00  €   4.595,00  €   4.895,00  €        2.695,00
Young Innovator Rate €           795,00  €            995,00  €   1.195,00  €   1.195,00  €   3.795,00

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

Important: Those companies that have booked a stand participation via the German Pavilion will continue to receive their tickets at the lower R&D / Investor / Government rate. Registration information will be shared directly by the organizing company at a later date.


Please visit the German Pavilion @ BioEurope Fall 2025 in Vienna

Germany@BioEurope Wien 2025

register now

Our latest News

discover more
Innovative medical products on their way to the clinic – GeneNovate successfully promotes entrepreneurial thinking in cutting-edge German research

Innovative medical products on their way to the clinic – GeneNovate successfully promotes entrepreneurial thinking in cutting-edge German research

After a pilot last year, GeneNovate, Germany’s first national entrepreneurship program for gene and cell therapies, took place for the second time. All participants in the program met in Berlin on 26 June for the joint closing event. There, they presented a total of 23 research projects to a high-caliber jury of business angels, venture […]

New Publication from Hummingbird Diagnostics GmbH: Early detection of Alzheimer’s disease using small RNAs. Results from the EPAD cohort

New Publication from Hummingbird Diagnostics GmbH: Early detection of Alzheimer’s disease using small RNAs. Results from the EPAD cohort

Alzheimer’s disease is the most common type of dementia, and early detection is important for better treatment. This study looked at small RNA molecules in the blood to see if they could help identify early signs of Alzheimer’s, especially in people with high levels of amyloid, a key Alzheimer’s marker. Researchers analyzed blood samples from […]

Medicine in the digital age: “MEDI:CUS” cloud for optimal healthcare

Medicine in the digital age: “MEDI:CUS” cloud for optimal healthcare

Data can save lives. However, in order for health data to be used for the benefit of patients, relevant data must be made available where it is needed. With the MEDI:CUS project, which is funded under the umbrella of the Forum Gesundheitsstandort Baden-Württemberg, the state of Baden-Württemberg is building a secure and data protection-compliant cloud-based […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp